Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Fairfield Financial Advisors LTD

Fairfield Financial Advisors LTD lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,921 shares of the medical equipment provider’s stock after purchasing an additional 1,645 shares during the quarter. Intuitive Surgical comprises 0.9% of Fairfield Financial Advisors LTD’s portfolio, making the stock its 22nd largest position. Fairfield Financial Advisors LTD’s holdings in Intuitive Surgical were worth $2,569,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the fourth quarter worth $82,517,000. Sycomore Asset Management grew its position in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC grew its position in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its position in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares of the company’s stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,579 shares of company stock worth $7,756,844 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 3.8 %

ISRG opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market cap of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. The company’s 50 day moving average is $571.36 and its 200 day moving average is $531.20.

Analysts Set New Price Targets

A number of research firms recently weighed in on ISRG. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Raymond James lifted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.